What You Should Know:
– Implicity, a leader in remote patient monitoring and cardiac data management, has received FDA 510(k) clearance for SignalHF1, a groundbreaking new algorithm within their remote monitoring solution.
– SignalHF1 algorithm empowers…
Continue Reading
Seoul-based medical equipment maker Samsung Medison has recently agreed to fully purchase Sonio, a foetal ultrasound AI company in France, for 126 billion won ($92 million). The four-year-old French startup has been developing IT solutions for…
Continue Reading
A trio of companies have introduced new advances in artificial intelligence designed to improve patient outcomes and reduce clinician burnout. RapidAI announced a new tool that helps frontline clinicians make decisions when minutes count in…
Continue Reading
The demand for home sleep apnea testing (HSAT) devices is escalating, particularly in the context of the coronavirus 2019 (COVID-19) pandemic. The absence of standardized development and verification procedures poses a significant challenge. This…
Continue Reading
Last month, an app named Rejoyn became the first FDA-cleared prescription digital therapeutic for patients with major depressive disorder. The app, which changes users’ behavior through various lessons and exercises, was developed by Otsuka…
Continue Reading
News
The American Hospital Association asks Congress to employ flexibility in any decisions to regulate AI in healthcare, proposing use of a sliding scale that is based on risk and the level of human oversight…
Continue Reading
Diagnostics startup Geneoscopy earned its first-ever FDA approval this week.
The St. Louis-based company received approval for ColoSense, its noninvasive colorectal cancer screening test. The test — which the FDA designated as a breakthrough device…
Continue Reading
What You Should Know:
– GE HealthCare announced the unveiling of SIGNA MAGNUS, a revolutionary head-only magnetic resonance imaging (MRI) scanner.
– This FDA 510(k) pending technology holds immense promise for unlocking new frontiers in neuroscience…
Continue Reading
What You Should Know:
– RapidAI, a global leader in AI-powered solutions for combating life-threatening vascular diseases, announced today the FDA 510(k) clearance for its innovative AngioFlow™ by RapidAI solution.
– The technology empowers interventional care…
Continue Reading
The FDA announced the Apple Watch atrial fibrillation (AFib) tool is qualified for use in clinical trials through its Medical Device Development Tools (MDDT) program, enabling researchers to use it to detect arrhythmias or…
Continue Reading
